Literature DB >> 28623677

Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.

Paul K Crane1, Emily Trittschuh2, Shubhabrata Mukherjee3, Andrew J Saykin4, R Elizabeth Sanders3, Eric B Larson5, Susan M McCurry6, Wayne McCormick3, James D Bowen7, Thomas Grabowski8, Mackenzie Moore9, Julianna Bauman9, Alden L Gross10, C Dirk Keene11, Thomas D Bird12, Laura E Gibbons3, Jesse Mez13.   

Abstract

INTRODUCTION: There may be biologically relevant heterogeneity within typical late-onset Alzheimer's dementia.
METHODS: We analyzed cognitive data from people with incident late-onset Alzheimer's dementia from a prospective cohort study. We determined individual averages across memory, visuospatial functioning, language, and executive functioning. We identified domains with substantial impairments relative to that average. We compared demographic, neuropathology, and genetic findings across groups defined by relative impairments.
RESULTS: During 32,286 person-years of follow-up, 869 people developed Alzheimer's dementia. There were 393 (48%) with no domain with substantial relative impairments. Some participants had isolated relative impairments in memory (148, 18%), visuospatial functioning (117, 14%), language (71, 9%), and executive functioning (66, 8%). The group with isolated relative memory impairments had higher proportions with ≥ APOE ε4 allele, more extensive Alzheimer's-related neuropathology, and higher proportions with other Alzheimer's dementia genetic risk variants. DISCUSSION: A cognitive subgrouping strategy may identify biologically distinct subsets of people with Alzheimer's dementia.
Copyright © 2017 the Alzheimer's Association. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cognition; Endophenotypes; Genetics; Heterogeneity; Neuropathology; Subgroups

Mesh:

Substances:

Year:  2017        PMID: 28623677      PMCID: PMC5723557          DOI: 10.1016/j.jalz.2017.04.011

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  20 in total

1.  A composite score for executive functioning, validated in Alzheimer's Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment.

Authors:  Laura E Gibbons; Adam C Carle; R Scott Mackin; Danielle Harvey; Shubhabrata Mukherjee; Philip Insel; S McKay Curtis; Dan Mungas; Paul K Crane
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Ann Intern Med       Date:  2007-10-16       Impact factor: 25.391

3.  Personalized medicine for effective Alzheimer disease treatment.

Authors:  Kenneth S Kosik
Journal:  JAMA Neurol       Date:  2015-05       Impact factor: 18.302

4.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

5.  Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

Authors:  M S Beeri; J Schmeidler; M Sano; J Wang; R Lally; H Grossman; J M Silverman
Journal:  Neurology       Date:  2006-09-26       Impact factor: 9.910

Review 6.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 8.  Personalized medicine in neurodegenerative diseases: how far away?

Authors:  Kristina Gotovac; Sanja Hajnšek; Marija Bošnjak Pašić; Nela Pivac; Fran Borovečki
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

9.  Phenotypic complexity, measurement bias, and poor phenotypic resolution contribute to the missing heritability problem in genetic association studies.

Authors:  Sophie van der Sluis; Matthijs Verhage; Danielle Posthuma; Conor V Dolan
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  20 in total

1.  Associations between recent and established ophthalmic conditions and risk of Alzheimer's disease.

Authors:  Cecilia S Lee; Eric B Larson; Laura E Gibbons; Aaron Y Lee; Susan M McCurry; James D Bowen; Wayne C McCormick; Paul K Crane
Journal:  Alzheimers Dement       Date:  2018-08-08       Impact factor: 21.566

2.  Pathologies Underlying Longitudinal Cognitive Decline in the Oldest Old.

Authors:  Madeline T Nguyen; Nora Mattek; Randy Woltjer; Diane Howieson; Lisa Silbert; Scott Hofer; Jeffrey Kaye; Hiroko Dodge; Deniz Erten-Lyons
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

Review 3.  Posterior Cortical Atrophy.

Authors:  Jonathan M Schott; Sebastian J Crutch
Journal:  Continuum (Minneap Minn)       Date:  2019-02

Review 4.  Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods.

Authors:  Mohamad Habes; Michel J Grothe; Birkan Tunc; Corey McMillan; David A Wolk; Christos Davatzikos
Journal:  Biol Psychiatry       Date:  2020-01-31       Impact factor: 13.382

5.  Measurement and Structure of Cognition in the Longitudinal Aging Study in India-Diagnostic Assessment of Dementia.

Authors:  Alden L Gross; Pranali Y Khobragade; Erik Meijer; Judith A Saxton
Journal:  J Am Geriatr Soc       Date:  2020-08       Impact factor: 5.562

6.  Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups.

Authors:  Julianna Bauman; Laura E Gibbons; Mackenzie Moore; Shubhabrata Mukherjee; Susan M McCurry; Wayne McCormick; James D Bowen; Emily Trittschuh; Maria Glymour; Jesse Mez; Andrew J Saykin; Kristen Dams-O'Conner; David A Bennett; Eric B Larson; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Neural correlates of domain-specific cognitive decline: The ARIC-NCS Study.

Authors:  Andrea L C Schneider; Matthew L Senjem; Aozhou Wu; Alden Gross; David S Knopman; Jeffrey L Gunter; Christopher G Schwarz; Thomas H Mosley; Rebecca F Gottesman; A Richey Sharrett; Clifford R Jack
Journal:  Neurology       Date:  2019-02-06       Impact factor: 9.910

8.  Associations Between Retinal Artery/Vein Occlusions and Risk of Vascular Dementia.

Authors:  Cecilia S Lee; Michael L Lee; Laura E Gibbons; Ryan T Yanagihara; Marian Blazes; Jason P Kam; Susan M McCurry; James D Bowen; Wayne C McCormick; Aaron Y Lee; Eric B Larson; Paul K Crane
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups.

Authors:  Colin Groot; Michel J Grothe; Shubhabrata Mukherjee; Irina Jelistratova; Iris Jansen; Anna Catharina van Loenhoud; Shannon L Risacher; Andrew J Saykin; Christine L Mac Donald; Jesse Mez; Emily H Trittschuh; Gregor Gryglewski; Rupert Lanzenberger; Yolande A L Pijnenburg; Frederik Barkhof; Philip Scheltens; Wiesje M van der Flier; Paul K Crane; Rik Ossenkoppele
Journal:  Neuroimage Clin       Date:  2021-04-03       Impact factor: 4.881

10.  Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers.

Authors:  Rik Ossenkoppele; Juhan Reimand; Ruben Smith; Antoine Leuzy; Olof Strandberg; Sebastian Palmqvist; Erik Stomrud; Henrik Zetterberg; Philip Scheltens; Jeffrey L Dage; Femke Bouwman; Kaj Blennow; Niklas Mattsson-Carlgren; Shorena Janelidze; Oskar Hansson
Journal:  EMBO Mol Med       Date:  2021-07-13       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.